top of page

entX Launches Investor Webinar Series with Strategic Growth Update from Bryn Jones

19 March 2026

Webinar Series – Episode 1 | Presented by Bryn Jones



In this opening session, Bryn provided a comprehensive overview of entX’s strategy, highlighting how our core capability in radioisotope sourcing, processing and purification underpins three high-growth sectors: healthcare, space, and defence.


Key highlights from the session include:

  • IsoMedica (Mines-to-Medicine): entX is addressing a critical global supply chain gap in radiopharmaceuticals by positioning itself as a Western supplier of key radioisotope precursors. With strong market demand and existing letters of intent in place, the IsoMedica facility remains on track for first commercial revenue in Q4 2026.


  • Significant Market Opportunity: The radiopharmaceutical sector continues to expand rapidly, with over 200 drugs in development and growing demand for isotopes such as Thorium-228. entX is strategically positioned to become a key supplier into this emerging market.


  • GenX Nuclear Battery Technology: entX’s GenX platform delivers long-life, maintenance-free power solutions for applications including remote sensors, defence systems, and space technologies. The technology already exceeds U.S. government performance targets and is progressing toward commercial deployment.


  • Radioisotope Heating Units (RHU): entX’s RHU technology is designed to enable lunar and space missions to survive extreme conditions. A flight heritage mission is scheduled for later this year, representing a major commercial catalyst.


  • Commercial Momentum: The business is transitioning from R&D into commercialisation, with near-term milestones including facility commissioning, contract conversion, prototype integration, and the upcoming RHU launch.


As Bryn noted, entX is approaching a pivotal inflection point, with multiple near-term catalysts expected across all three pillars over the next 12 months.


This webinar marks the first in a multi-part series designed to provide deeper insights into our business.


Watch Episode 2 on our IsoMedica business featuring Massey de los Reyes.

Watch Episode 3 on our GenX technology featuring Scott Edwards.

Watch Episode 4, on our RHU featuring Scott Edwards.


Recent News:

2 June 2026

Looking Ahead: Managing Director's Update

25 May 2026

RHU Webinar: Surviving the Lunar Night

21 May 2026

Telix and entX Sign Agreement for Critical Medical Isotope Precursors

See More entX News

bottom of page